Skip to main content
NCBI home page
British Journal of Industrial Medicine logoLink to British Journal of Industrial Medicine
. 1986 Nov;43(11):760–768. doi: 10.1136/oem.43.11.760

Physiologicomathematical model for studying human exposure to organic solvents: kinetics of blood/tissue n-hexane concentrations and of 2,5-hexanedione in urine.

L Perbellini, P Mozzo, F Brugnone, A Zedde
PMCID: PMC1007749  PMID: 3790456

Abstract

The physiologicomathematical model with eight compartments described allows the simulation of the absorbtion, distribution, biotransformation, excretion of an organic solvent, and the kinetics of its metabolites. The usual compartments of the human organism (vessel rich group, muscle group, and fat group) are integrated with the lungs, the metabolising tissues, and three other compartments dealing with the metabolic kinetics (biotransformation, water, and urinary compartments). The findings obtained by mathematical simulation of exposure to n-hexane were compared with data previously reported. The concentrations of n-hexane in alveolar air and in venous blood described both in experimental and occupational exposures provided a substantial validation for the data obtained by mathematical simulation. The results of the urinary excretion of 2,5-hexanedione given by the model were in good agreement with data already reported. The simulation of an exposure to n-hexane repeated five days a week suggested that the solvent accumulates in the fat tissue. The half life of n-hexane in fat tissue equalled 64 hours. The kinetics of 2,5-hexanedione resulting from the model suggest that occupational exposure results in the presence of large amounts of 2,5-hexanedione in the body for the whole working week.

Full text

PDF
760

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen M. E. A physiologically based toxicokinetic description of the metabolism of inhaled gases and vapors: analysis at steady state. Toxicol Appl Pharmacol. 1981 Sep 30;60(3):509–526. doi: 10.1016/0041-008x(81)90338-0. [DOI] [PubMed] [Google Scholar]
  2. Baker T. S., Rickert D. E. Dose-dependent uptake, distribution, and elimination of inhaled n-hexane in the Fischer-344 rat. Toxicol Appl Pharmacol. 1981 Dec;61(3):414–422. doi: 10.1016/0041-008x(81)90364-1. [DOI] [PubMed] [Google Scholar]
  3. Bischoff K. B., Dedrick R. L., Zaharko D. S., Longstreth J. A. Methotrexate pharmacokinetics. J Pharm Sci. 1971 Aug;60(8):1128–1133. doi: 10.1002/jps.2600600803. [DOI] [PubMed] [Google Scholar]
  4. Brugnone F., Perbellini L., Grigolini L., Apostoli P. Solvent exposure in a shoe upper factory. Int Arch Occup Environ Health. 1978 Sep 15;42(1):51–62. doi: 10.1007/BF00385711. [DOI] [PubMed] [Google Scholar]
  5. Böhlen P., Schlunegger U. P., Läuppi E. Uptake and distribution of hexane in rat tissues. Toxicol Appl Pharmacol. 1973 Jun;25(2):242–249. doi: 10.1016/s0041-008x(73)80010-9. [DOI] [PubMed] [Google Scholar]
  6. Droz P. O., Guillemin M. P. Human styrene exposure. V. Development of a model for biological monitoring. Int Arch Occup Environ Health. 1983;53(1):19–36. doi: 10.1007/BF00406174. [DOI] [PubMed] [Google Scholar]
  7. Fernández J. G., Droz P. O., Humbert B. E., Caperos J. R. Trichloroethylene exposure. Simulation of uptake, excretion, and metabolism using a mathematical model. Br J Ind Med. 1977 Feb;34(1):43–55. doi: 10.1136/oem.34.1.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fiserova-Bergerova V., Vlach J., Singhal K. Simulation and prediciton of uptake, distribution, and exhalation of organic solvents. Br J Ind Med. 1974 Jan;31(1):45–52. doi: 10.1136/oem.31.1.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Iwata M., Takeuchi Y., Hisanaga N., Ono Y. A study on biological monitoring of n-hexane exposure. Int Arch Occup Environ Health. 1983;51(3):253–260. doi: 10.1007/BF00377756. [DOI] [PubMed] [Google Scholar]
  10. Mapleson W. W. Circulation-time models of the uptake of inhaled anaesthetics and data for quantifying them. Br J Anaesth. 1973 Apr;45(4):319–334. doi: 10.1093/bja/45.4.319. [DOI] [PubMed] [Google Scholar]
  11. Mutti A., Falzoi M., Lucertini S., Arfini G., Zignani M., Lombardi S., Franchini I. n-Hexane metabolism in occupationally exposed workers. Br J Ind Med. 1984 Nov;41(4):533–538. doi: 10.1136/oem.41.4.533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Perbellini L., Amantini M. C., Brugnone F., Frontali N. Urinary excretion of n-hexane metabolites. A comparative study in rat, rabbit and monkey. Arch Toxicol. 1982 Sep;50(3-4):203–215. doi: 10.1007/BF00310852. [DOI] [PubMed] [Google Scholar]
  13. Perbellini L., Bartolucci G. B., Brugnone F., De Rosa E., Valentini F. Il 2,5-esandione nel controllo biologico dell'esposizione professionale a n-esano. Med Lav. 1985 Jan-Feb;76(1):35–43. [PubMed] [Google Scholar]
  14. Perbellini L., Brugnone F., Caretta D., Maranelli G. Partition coefficients of some industrial aliphatic hydrocarbons (C5-C7) in blood and human tissues. Br J Ind Med. 1985 Mar;42(3):162–167. doi: 10.1136/oem.42.3.162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Perbellini L., Brugnone F., Faggionato G. Urinary excretion of the metabolites of n-hexane and its isomers during occupational exposure. Br J Ind Med. 1981 Feb;38(1):20–26. doi: 10.1136/oem.38.1.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ramsey J. C., Andersen M. E. A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicol Appl Pharmacol. 1984 Mar 30;73(1):159–175. doi: 10.1016/0041-008x(84)90064-4. [DOI] [PubMed] [Google Scholar]
  17. Sato A., Nakajima T., Fujiwara Y., Murayama N. A pharmacokinetic model to study the excretion of trichloroethylene and its metabolites after an inhalation exposure. Br J Ind Med. 1977 Feb;34(1):56–63. doi: 10.1136/oem.34.1.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Soter N. A., Wasserman S. I., Austen K. F. Cold urticaria: release into the circulation of histamine and eosinophil chemotactic factor of anaphylaxis during cold challenge. N Engl J Med. 1976 Mar 25;294(13):687–690. doi: 10.1056/NEJM197603252941302. [DOI] [PubMed] [Google Scholar]
  19. Veulemans H., Van Vlem E., Janssens H., Masschelein R., Leplat A. Experimental human exposure to n-Hexane. Study of the respiratory uptake and elimination, and of n-Hexane concentrations in peripheral venous blood. Int Arch Occup Environ Health. 1982 Feb;49(3-4):251–263. doi: 10.1007/BF00377934. [DOI] [PubMed] [Google Scholar]
  20. Wagner J. G. Method for estimating rate constants for absorption, metabolism, and elimination from urinary excretion data. J Pharm Sci. 1967 Apr;56(4):489–494. doi: 10.1002/jps.2600560413. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Industrial Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES